What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

To evaluate the hemostatic potency of factor IX (wild-type vs. Padua) in mouse models of hemophilia B.

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

Authors

This comparison demonstrates improved hemostatic potency of factor IX Padua in hemophilia B, suggesting lower dosing may enhance therapy.

To evaluate the hemostatic potency of factor IX (wild-type vs. Padua) in mouse models of hemophilia B.
Compared hemostatic effects of rFIX-Padua and rFIX-WT in HB mice with two injury models.
Used tail-clip and tail vein transection assays to quantify blood loss after protein administration.
Employed affinity chromatography for protein purification.
rFIX-Padua showed a significant reduction in blood loss compared to rFIX-WT at equivalent doses.
rFIX-Padua resulted in a 4-6-fold increased potency in vivo compared to rFIX-WT.
Dose-dependence of rFIX for blood loss was quantified using logistic curve fitting, showing clear differences in EC50 values.

Ben Samelson-Jones (2025) studied this question.

View Full Paper

Ask AI

Bookmark